Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by wizzdumbon Jun 18, 2021 3:16pm
124 Views
Post# 33412495

RE:Resurgence in early Fall, starting in September...

RE:Resurgence in early Fall, starting in September...

Testing not going away. I am surprised how much this concern seems to be impacting the stock price based on comments posted here previously by Adelaide. She seems to believe it is the main reason the shares are not advancing. I would say that based on what other companies out there Microbix did basically nothing to take advantage of a "covid angle" as a way to artificially boost the share price. Seems odd they are being punished for absolutely nothing now.

Everything looking positive still with two record quarters behind us and two more to come. Shocking how low volumes have been the past few weeks. Continue to hold and accumulate. Eerily quiet on news front, hopefully big things brewing!!


 

<< Previous
Bullboard Posts
Next >>